Please Wait...

Cardiac Safety

World-renowned scientific expertise, regulatory leadership and integrated technology for high quality centralized cardiac safety trials.

Cardiovascular Safety Services from Bioclinica

With over 25 years of experience in Cardiac Safety monitoring services, Bioclinica is a recognized global leader in providing comprehensive services with unrivalled scientific and technical leadership. Bioclinica's medical and scientific team, consisting of board-certified cardiologists and active members of the Cardiac Safety Research Consortium, has strong experience in successfully designing and supporting studies that require cardiac safety monitoring. Our focus goes beyond the single study and across the entire cardiac safety profile of the study compound from Phase I–IV. With experience working alongside the ICH, FDA, EMA, PMDA, and SFDA in the development of regulatory and industry guidelines, Bioclinica is the smart choice to support the design and conduct of cardiac safety studies around the globe.

ECG MEASUREMENTS

Manual and automated ECG analysis and Digital Holter analysis.
LEARN MORE

THOROUGH QT STUDIES

Innovative and conventional TQT study design and support.
LEARN MORE

BLOOD PRESSURE

Ambulatory and Automated Blood Pressure and Pulse Wave Analysis.
LEARN MORE

CARDIOVASCULAR IMAGING

Cardiac safety endpoints using a range of imaging modalities.
LEARN MORE

PROTOCOL DESIGN AND EXPERT REPORTING

Study design and Consultative Services.
LEARN MORE

WEBHEART™ PLATFORM

Robust, validated trial management tool.
LEARN MORE

SCIENTIFIC & REGULATORY EXPERTISE

30+ years of proven strategic expertise.
LEARN MORE

 

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Clinical #datamanagement is essential to ensure high-quality data in #clinicaltrials, but the components are comple… https://t.co/klK81O6YA2
Bioclinica (2 days ago)
Congratulations to Jeff Heilbraun, M.S., VP, Medical & Scientific Affairs, for his latest article on cardiovascular… https://t.co/JSuEaeQOYh
Bioclinica (1 week ago)
Changes are a fact of life - and of #clinicaltrial design. But planning and budgeting for your trial don’t have to… https://t.co/wsfMPAwLxR
Bioclinica (3 weeks ago)
Don't compromise with manual systems and spreadsheets. As an entry-level system with phased implementation, Bioclin… https://t.co/dYDJO4Qh7S
Bioclinica (4 weeks ago)
Our webinar on Neuroimaging in Parkinson’s Disease is tomorrow at 10:30 a.m. EDT. Register at:… https://t.co/4j0FGeXG0B
Bioclinica (4 weeks ago)
Today is World Ovarian Cancer Day. Ovarian cancer has the lowest survival rate of all female cancers. #Bioclinica p… https://t.co/1nMGahTMaz
Bioclinica (4 weeks ago)